BioAlliance Pharma: Publication of the 2009 Annual Financial Report

PARIS--(Business Wire)--
Regulatory News:

BioAlliance Pharma SA (Paris:BIO)(Euronext Paris: BIO), a company dedicated to
the treatment and supportive care of cancer and AIDS patients, announces today
that its 2009 Annual Financial Report has been sent to the French Market
Authorities and may be consulted at the http://www.bioalliancepharma.com
website,

http://www.bioalliancepharma.com/eng/Investisseurs/Information-reglementee-AMF

The Annual Financial Report comprises the report by the Chairman of the
Supervisory Board on the Board`s activities and on internal controls, the
statutory Auditors` fees, and the annual information document.

About BioAlliance Pharma

As a preferred partner for hospital-based specialists, BioAlliance Pharma is a
company which develops innovative products, especially in the fields of
opportunistic infections and chemotherapy complications. In areas where medical
needs are insufficiently met, its targeted approaches help overcome drug
resistance and improve patient health & quality of life. BioAlliance Pharma`s
ambition is to become a leading player in these fields by coupling innovation to
patient needs.

For more information, visit the BioAlliance Pharma web site at
www.bioalliancepharma.com

BioAlliance Pharma SA
Dominique Costantini, President and CEO
Tel.: +33 1 45 58 76 01
dominique.costantini@bioalliancepharma.com
or
Nicolas Fellmann, CFO
Tel.: +33 1 45 58 71 00
nicolas.fellmann@bioalliancepharma.com
or
ALIZE RP
Caroline Carmagnol
Tel.: +33 6 64 18 99 59
caroline@alizerp.com

Copyright Business Wire 2010